Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.17B P/E - EPS this Y 15.10% Ern Qtrly Grth -
Income -616.43M Forward P/E -13.10 EPS next Y 10.10% 50D Avg Chg 7.00%
Sales 54k PEG 0.58 EPS past 5Y - 200D Avg Chg 41.00%
Dividend N/A Price/Book 9.14 EPS next 5Y -20.20% 52W High Chg -
Recommedations 2.70 Quick Ratio 8.31 Shares Outstanding 61.66M 52W Low Chg 120.00%
Insider Own 0.27% ROA -34.53% Shares Float 61.52M Beta 0.55
Inst Own 83.86% ROE -70.30% Shares Shorted/Prior 6.02M/5.11M Price 99.99
Gross Margin - Profit Margin - Avg. Volume 1,472,638 Target Price 97.86
Oper. Margin -1,010,483.30% Earnings Date Aug 3 Volume Change 0.00%
About Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

ARNA Chatroom

User Image grampslol Posted - 3 weeks ago

$UTHR wanted $LQDA 's superior DPI Yutrepia but was wisely rejected by them in 2018 so they got $MNKD's generic treprostinil world wide rights for chump change. However, they bet the farm on $ARNA's pah Ralinepag in an over $1.2Billion partial rights deal. ARNA was later b/o by PFE. $UTHR will Sanofi $MNKD it's not a matter of if only when. https://www.fiercebiotech.com/biotech/arena-bags-big-deal-united-for-pah-drug-ralinepag

User Image Zinwrath Posted - 06/30/24

@Jlh50 maybe that's why they got rid of two executives also .... Quoting from Sellas "Stacy Yeung—recently promoted to Associate General Counsel and Head of Compliance—will now oversee the New York-based company’s legal matters." This is the woman who helped $ARNA be acquired by Pfizer for $6.7 Billion dollars

User Image celebratelife Posted - 1 month ago

$CGTX Facta, CEO is not just a "detail". Leadership matters! Otherwise just put a janitor as CEO and save a lot of money. have not blamed many CEOs (good CEOs) -- but I have blamed some lousy ones like Richard Paulson of $KPTI that you mentioned, and Jack Lief of $ARNA whom we got fired and the company got a new CEO and Pfizer ($PFE) bought them out. $CGTX's CEO Lisa Ricciardi is super hyper and the company's admin side has been very sloppy. But the science is great, and Lisa has the perfect profile and has the right connections (and so does the Board) to get the company a great price from Pharma - upon good data).

User Image celebratelife Posted - 1 month ago

@Factanonverba CEO is not just a "detail". Leadership matters! Otherwise just put a janitor as CEO and save a lot of money. have not blamed many CEOs (good CEOs) -- but I have blamed some lousy ones like Richard Paulson of $KPTI that you mentioned, and Jack Lief of $ARNA whom we got fired and the company got a new CEO and Pfizer ($PFE) bought them out. $CGTX's CEO Lisa Ricciardi is super hyper and the company's admin side has been very sloppy. But the science is great, and Lisa has the perfect profile and has the right connections (and so does the Board) to get the company a great price from Pharma - upon good data).

User Image SlapThatAsssk Posted - 2 months ago

$IBRX - adding cheapies here under $7 to average UP to core. Seen this bull shit multiple times over the years as a biotech ramps for commercialization and on verge on huge growth while they suppress the stock price. Yawn 🥱 $LVGO $ALBO $ARNA $SGEN

User Image robo84 Posted - 2 months ago

$JAGX How much will Jaguar generate in sales with the new dog product? Animal products are in high demand and also bring in strong sales, look at the Indian company "Zoetis", it is over 100$ $ZTS $ARNA $SGEN https://www.canalevia.com/

User Image Quantumup Posted - 04/30/24

Baird initiated $LBPH Outperform/$36: As the neuroscience biotech spinout of $ARNA (acquired by $PFE 2022 for $6.7B), $LBPH' agents came out of the same "leading" GPCR drug discovery engine as $ARNA' agents and "just like Arena a few years ago," Longboard has two lead agents that each "appear on track to have a meaningfully differentiated best-in-class profile for an area of high interest to large biotech/pharma companies."

User Image robo84 Posted - 04/29/24

$SLS Time for Stacy... 😇😉🤑She will lead the takeover, which is why she was hired at Sellas... $ARNA $ZTS $PFE

User Image RixtaRox_7Billion Posted - 4 months ago

$ARNA ALT is gonna be a multi bagger coming off $9 https://www.globenewswire.com/news-release/2024/03/20/2849265/0/en/Altimmune-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provide-Business-Update-on-March-27-2024.html

User Image robo84 Posted - 4 months ago

$SLS SlS Buyout is safe...🤑 $PFE $ABBV $ARNA

User Image ians Posted - 5 months ago

$VTYX Is there Anyone here who had invested in $ARNA who’s trying to see if lighting can strike twice? It eventually got BO by PFE for $100/sh. I remember WS beat that up to $5 level too much like they’ve done VTYX. If mgmt. reports +ve data for UC & Crohn’s, this could easily recaptured $16-24 again 🤑☘️💎

User Image grampslol Posted - 5 months ago

$MNKD @kevinmik I'm with you, bro ! Remember, how UTHR gave $ARNA $1.2 Billion upfront plus royalties and other add-ons for all rights, but to Asia, for their oral pah drug... I'm thinking what we're going to get from Cipla in 2024 will Dwarf that !! And just wait til the Biggies start bidding for Afrezza Kids/Adolescents later in 2024 ! #Liftyourhandsinpraise #TodamoonwithMikey #fordiabetescareitsHairplugBills #payinsidersmorenow

User Image ern1in Posted - 8 months ago

$ARNA , also accumulating more $TGTX. TG THERAPEUTICS. FDA APPROVED BRIUMVI FOR MS. 🦧

User Image Nexus85666 Posted - 8 months ago

$ARNA working on saving people from the side effects of the vax ☠️

User Image infomike Posted - 8 months ago

$GNPX so many shorts trying to grind this to zero on the assumption there will be a RS (and assuming that would be the end of the road, which it is not … look at $ARNA) … you all are a bunch of empty flesh bags with acne. Karma will catch up with you.

User Image hospitalphysician Posted - 9 months ago

@Stockman824 Tell me about it. I owned $ARNA for years. Watching the serial stock awards and offering was painful.

User Image DrEddySusman Posted - 09/26/23

$BLRX what do $ARNA $TRIL $PRVB all have in common. Companies that i owned that were acquired at a massive premium. Just reflected back after seeing the buyout of Intercept. Id be damned if our platform company at Bioline doesnt see the same fate. Insanely undervalued here. Time will tell!!

User Image ians Posted - 10 months ago

@biffermeister Cuz I’m not a trader. And yeah I pray to the Lord Jesus 🙏 Why? Cuz he always come thru for me. I prayed for $65-70 for $ARNA but guess what? he granted us with $100 PFE BO.☘️ So please Lord I humbly pray, grant us $AMRN LT shareholders $9-12 🙏

User Image Thestocktraderhubzee Posted - 10 months ago

WATCHLIST SEP 14 2023 $CODA Global Partners Maintains Buy on Coda Octopus Group, Lowers Price Target to $10 $CRL TD Cowen Initiates Coverage On Charles River with Market Perform Rating, Announces Price Target of $212 $AAPL B of A Securities Maintains Neutral on Apple, Lowers Price Target to $208 $ARNA Argus Research Maintains Buy on Moderna, Lowers Price Target to $140 $NTRS Wells Fargo Maintains Overweight on Northern Trust, Lowers Price Target to $90

User Image TCLutz Posted - 1 year ago

$TTOO .740 seems to be the floor today. Triple bottomed. Pending FDA approval on a 74% accurate sepsis diagnostic test. Honestly, I don’t see much more down side. It’s already down -99% in a year, -94% in 6 months, and they’re not issuing new shares. Q2 restructuring will likely be a good thing - even though it led to a massive sell off a month ago. There’s the bearish argument… and then there’s just stupid: “it’s down -99% so I’m going to continue shorting…” $SPY $PFE $INO $ARNA

User Image LBYZ Posted - 1 year ago

$ARNA so.. Pfizer just bought this for 6Billion ! No wonder ‘ since they made Billions during Pandemic!

User Image dms_85 Posted - 1 year ago

$ARNA why hasn’t this stock traded in a while? Is it halted?

User Image Galacticon Posted - 1 year ago

@Nostradamus696 I was on that $ARNA train as well and looking for more opportunities. $SPPI is another that I am eyeballing!

User Image Nostradamus696 Posted - 1 year ago

Been a part of $ARNA $CCXI $PRVB $BHVN. Have a good quality of life. If Altimmune isn't next... I give up my moniker of Nostradamus

User Image GPS_21_vs_5_wBAT Posted - 1 year ago

$ARNA $SLS

User Image InvestorCuse Posted - 1 year ago

$SLS when a message board is all FUD/Bearish, ask yourself why. Why do they want the price to drop? Then buy/add. (If you’ve done your DD on the value and upside.) Shorts did the same tricks to $ARNA, and it’s now $99 ps. I bought at $5 and sold at $70.

User Image Galacticon Posted - 1 year ago

$CANOQ heard the same fud on the $ARNA and $PRVB boards. Hoping to make this another one where I cash out and move on to the next. Just sayin bears gotta bear!

User Image ern1in Posted - 1 year ago

$ARNA & $TGTX > 12/28/22 FDA APPROVED BRIUMVI FOR MS. Must own bio's .......

User Image RCI04001 Posted - 03/30/23

@Thatwasswell7 @DewMaster True story: I sold my $ARNA prior to BO to buy more $CLVSQ … Pat thanks me

User Image risenhoover Posted - 03/27/23

$ARNA ARNA / Arena Pharmaceuticals, Inc. Price Target Updated https://fintel.io/sfo/us/arna?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

Analyst Ratings
HC Wainwright & Co. Neutral Feb 9, 22
Cantor Fitzgerald Neutral Dec 21, 21
Citigroup Neutral Dec 14, 21
JMP Securities Market Perform Dec 14, 21
SVB Leerink Market Perform Dec 14, 21
RBC Capital Sector Perform Dec 14, 21
Credit Suisse Neutral Dec 14, 21
Jefferies Hold Dec 14, 21
Needham Hold Dec 13, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dallas Jayson Donald Alexander Director Director Jun 15 Sell 66.36 1,223 81,158 7,152 06/15/21
Lisicki Robert EVP, Chief Commercia.. EVP, Chief Commercial Officer Feb 04 Option 40.95 17,500 716,625 26,941 02/04/21
Lisicki Robert EVP, Chief Commercia.. EVP, Chief Commercial Officer Feb 04 Sell 78.52 17,500 1,374,100 9,441 02/04/21
Munshi Amit President and CEO President and CEO Jan 20 Option 15.5 100,000 1,550,000 57,750 01/20/21
Munshi Amit President and CEO President and CEO Jan 20 Sell 80.46 100,000 8,046,000 7,750 01/20/21
Munshi Amit President and CEO President and CEO Jan 14 Sell 74.87 14,877 1,113,841 7,750 01/14/21
Lisicki Robert EVP, Chief Commercia.. EVP, Chief Commercial Officer Dec 03 Sell 65.88 3,872 255,087 12/03/20